Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans
Katherine A. Richards(University of Rochester Medicine), Andrea J. Sant(University of Rochester Medical Center), David J. Topham(University of Rochester Medicine), Theresa Fitzgerald(Office of Infectious Diseases), Savannah A Moritzky(University of Rochester Medicine), Ian Shannon(National Institutes of Health), John J. Treanor(University of Rochester Medicine), Angela R Branche(University of Rochester), Hongmei Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jennifer L. Nayak(University of Rochester Medicine)
Cited by 59
Related Papers
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
|Cochrane Database of Systematic Reviews|2017|648
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
|The Lancet Infectious Diseases|2017|473
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
|Cell|2021|309
The Kinetic Stability of MHC Class II:Peptide Complexes Is a Key Parameter that Dictates Immunodominance
|Immunity|2005|232
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
|Cell Reports Medicine|2022|168